{
    "clinical_study": {
        "@rank": "131388", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase II trial to study the effectiveness of docetaxel and ifosfamide in treating\n      women who have metastatic breast cancer."
        }, 
        "brief_title": "Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the efficacy of docetaxel and ifosfamide as first-line chemotherapy in women\n           with metastatic breast cancer.\n\n        -  Determine the response rate and duration of response of patients treated with this\n           regimen.\n\n        -  Determine the time to treatment failure and survival of patients treated with this\n           regimen.\n\n        -  Determine the toxicity of this regimen in these patients.\n\n        -  Determine the quality of life of patients treated with this regimen.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive docetaxel IV over 1 hour on day 1 and ifosfamide IV over 1 hour (beginning\n      1 hour after docetaxel infusion) on days 1-3. Treatment continues every 4 weeks in the\n      absence of disease progression or unacceptable toxicity.\n\n      Quality of life is assessed at baseline, every month during study, and then every 3 months\n      after completion of study.\n\n      Patients are followed every 3 months.\n\n      PROJECTED ACCRUAL: A total of 15-42 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed metastatic breast cancer\n\n          -  Bidimensionally measurable lesions\n\n               -  The following are not considered measurable:\n\n                    -  Bone lesions\n\n                    -  Leptomeningeal disease\n\n                    -  Ascites\n\n                    -  Pleural/pericardial effusion\n\n                    -  Inflammatory breast disease\n\n                    -  Lymphangitis cutis/pulmonis\n\n          -  Disease progression after hormonal therapy allowed provided at least 1 month since\n             last therapeutic manipulation\n\n          -  No CNS metastases\n\n          -  Hormone receptor status:\n\n               -  Not specified\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  21 to 75\n\n        Sex:\n\n          -  Female\n\n        Menopausal status:\n\n          -  Not specified\n\n        Performance status:\n\n          -  ECOG 0-2 OR\n\n          -  Zubrod 0-2\n\n        Life expectancy:\n\n          -  More than 12 weeks\n\n        Hematopoietic:\n\n          -  WBC at least 4,000/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n          -  Hemoglobin at least 11 g/dL\n\n        Hepatic:\n\n          -  Bilirubin no greater than 1.25 times upper limit of normal (ULN)\n\n          -  SGOT no greater than 1.25 times ULN\n\n        Renal:\n\n          -  Creatinine clearance at least 60 mL/min\n\n        Cardiovascular:\n\n          -  No history of congestive heart failure\n\n          -  No myocardial infarction within the past 6 months\n\n          -  No active ischemic heart disease\n\n          -  No uncontrolled hypertension\n\n        Other:\n\n          -  Not pregnant\n\n          -  No other prior or concurrent malignancy except properly treated basal cell skin\n             cancer or carcinoma in situ of the cervix\n\n          -  No other medical or psychiatric diseases that would preclude study\n\n          -  No geographical situation that would preclude study\n\n          -  No history of alcohol abuse\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior adjuvant chemotherapy including ifosfamide or docetaxel\n\n          -  No prior systemic chemotherapy for metastatic breast cancer\n\n        Endocrine therapy:\n\n          -  See Disease Characteristics\n\n          -  No concurrent corticoids, gestagens, or androgens unless strictly indicated\n\n        Radiotherapy:\n\n          -  Not specified\n\n        Surgery:\n\n          -  Not specified\n\n        Other:\n\n          -  No concurrent drinks containing caffeine or alcohol"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 9, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00026078", 
            "org_study_id": "GOCS-02-BR-01", 
            "secondary_id": [
                "CDR0000068969", 
                "NCI-V01-1670"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "docetaxel", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "ifosfamide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ifosfamide", 
                "Isophosphamide mustard", 
                "Docetaxel"
            ]
        }, 
        "keyword": [
            "stage IV breast cancer", 
            "recurrent breast cancer"
        ], 
        "lastchanged_date": "August 6, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/GOCS-02-BR-01"
        }, 
        "location": [
            {
                "contact": {
                    "email": "gocsbhb@bvconline.com.ar", 
                    "last_name": "Alberto Omar Romero, MD", 
                    "phone": "54-291-453-9848"
                }, 
                "facility": {
                    "address": {
                        "city": "Bahia Blanca", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "8000"
                    }, 
                    "name": "Policlinica Privada Instituto De Medicina Nuclear"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jperez@criba.edu.ar", 
                    "last_name": "Juan Eduardo Perez, MD", 
                    "phone": "54-291-452-5667"
                }, 
                "facility": {
                    "address": {
                        "city": "Bahia Blanca", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "8000"
                    }, 
                    "name": "Grupo Oncologico Cooperativo del Sur"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sergio Grasso, MD", 
                    "phone": "54-221-4845088"
                }, 
                "facility": {
                    "address": {
                        "city": "Gonnet", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "1987 MB"
                    }, 
                    "name": "St. Joseph Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Eduardo Heriberto Ortiz, MD", 
                    "phone": "54-2954-29-715"
                }, 
                "facility": {
                    "address": {
                        "city": "Santa Rosa", 
                        "country": "Argentina", 
                        "state": "La Pampa", 
                        "zip": "6300"
                    }, 
                    "name": "Sanatorio Santa Rosa S.R.L."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ricrodri@copetel.com.ar", 
                    "last_name": "Ricardo L. Rodriguez, MD", 
                    "phone": "54-223-479-3283"
                }, 
                "facility": {
                    "address": {
                        "city": "Mar del Plata", 
                        "country": "Argentina", 
                        "zip": "7600"
                    }, 
                    "name": "C.R I O."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bleone@satlink.com", 
                    "last_name": "Bernardo A. Leone, MD", 
                    "phone": "54-299-448-5247"
                }, 
                "facility": {
                    "address": {
                        "city": "Neuquen", 
                        "country": "Argentina"
                    }, 
                    "name": "Unidad Oncologica Del Neuquen"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "medominquez@3net.com.ar", 
                    "last_name": "Maria Ester Dominguez, MD", 
                    "phone": "0983-33450"
                }, 
                "facility": {
                    "address": {
                        "city": "Tres Arroyos", 
                        "country": "Argentina", 
                        "zip": "7500"
                    }, 
                    "name": "Centro Oncologico Tres Arroyos"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gilberto Morgan Villela, MD", 
                    "phone": "523-641-5081"
                }, 
                "facility": {
                    "address": {
                        "city": "Guadalajara", 
                        "country": "Mexico", 
                        "state": "Jalisco", 
                        "zip": "4430"
                    }, 
                    "name": "Centro Medico Nacional de Occidente"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Argentina", 
                "Mexico"
            ]
        }, 
        "official_title": "Docetaxel (DTX) - Ifosfamide (IFX) As First Line Chemotherapy In Metastatic Breast Cancer", 
        "overall_official": {
            "affiliation": "Unidad Oncologica Del Neuquen", 
            "last_name": "Bernardo A. Leone, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": {
            "measure": "Response rate", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00026078"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time to treatment failure", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Duration of response", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Survival", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Toxicity as assessed by CTC version  2.0", 
                "safety_issue": "Yes"
            }, 
            {
                "measure": "Quality of life as assessed by Schipper's Functional Living Index - Cancer", 
                "safety_issue": "No"
            }
        ], 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Grupo Oncologico Cooperativo del Sur", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2001", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2006"
    }, 
    "geocoordinates": {
        "C.R I O.": "-37.98 -57.59", 
        "Centro Medico Nacional de Occidente": "20.674 -103.344", 
        "Centro Oncologico Tres Arroyos": "-38.376 -60.278", 
        "Grupo Oncologico Cooperativo del Sur": "-38.712 -62.268", 
        "Policlinica Privada Instituto De Medicina Nuclear": "-38.712 -62.268", 
        "Sanatorio Santa Rosa S.R.L.": "-36.623 -64.286", 
        "St. Joseph Medical Center": "-34.889 -58.021", 
        "Unidad Oncologica Del Neuquen": "-38.949 -68.066"
    }
}